Cover Image

A novel risk score to predict survival in advanced heart failure due to cardiac amyloidosis

Cardiac amyloidosis, caused by deposition of immunoglobulin light chains (AL) or transthyretin (ATTR), carries a poor prognosis. Established risk scores for amyloidosis may not predict outcomes in those patients who develop advanced heart failure and who are potential candidates for heart transplant...

Full description

Saved in:
Bibliographic Details
Main Authors: Kreußer, Michael (Author) , Volz, Martin J. (Author) , Knop, Benjamin (Author) , Ehlermann, Philipp (Author) , Schmack, Bastian (Author) , Ruhparwar, Arjang (Author) , Hegenbart, Ute (Author) , Schönland, Stefan (Author) , Katus, Hugo (Author) , Raake, Philip (Author)
Format: Article (Journal)
Language:English
Published: 2020
In: Clinical research in cardiology
Year: 2020, Volume: 109, Issue: 6, Pages: 700-713
ISSN:1861-0692
DOI:10.1007/s00392-019-01559-y
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s00392-019-01559-y
Get full text
Author Notes:Michael M. Kreusser, Martin J. Volz, Benjamin Knop, Philipp Ehlermann, Bastian Schmack, Arjang Ruhparwar, Ute Hegenbart, Stefan O. Schönland, Hugo A. Katus, Philip W. Raake
Description
Summary:Cardiac amyloidosis, caused by deposition of immunoglobulin light chains (AL) or transthyretin (ATTR), carries a poor prognosis. Established risk scores for amyloidosis may not predict outcomes in those patients who develop advanced heart failure and who are potential candidates for heart transplantation. Here, we aimed to identify predictive parameters for patients with severe heart failure due to amyloidosis.
Item Description:Gesehen am 17.11.2020
Published online: 19 October 2019
Physical Description:Online Resource
ISSN:1861-0692
DOI:10.1007/s00392-019-01559-y

Similar Items